The CDC's Morbidity and Mortality Weekly Report ( MMWR) resumed publishing after an unprecedented 2-week hiatus, but without the three H5N1 avian influenza papers that were slated to publish on Jan.
A recent study conducted on human A(H5N1) cases in the United States found that conjunctivitis was the primary symptom ...
A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...
Get the latest on crucial health initiatives, research breakthroughs, and policy changes impacting public health and ...
DALLAS - Mangoceuticals, Inc. (NASDAQ: MGRX), a telemedicine company focused on men's wellness products with a market capitalization of $8.12 million, has announced progress in its H1N1 efficacy study ...